SeaStar Medical has been notified that it does not meet Nasdaq’s minimum stockholders’ equity requirement for continued listing. The notice does not immediately affect the company’s listing, but SeaStar must submit a plan to regain compliance by January 4, 2027.
- Nasdaq’s rule requires at least $2.5 million in stockholders’ equity for companies with a market value of listed securities below $35 million and annual net income below $500,000. Nasdaq said SeaStar’s latest quarterly report showed it was out of compliance with that requirement.
- SeaStar plans to submit a compliance plan by the January 4 deadline. Nasdaq may give the company an additional 180 days from the November 20 notice to regain compliance if it accepts the plan.
- The company’s shares can remain listed for now, provided SeaStar continues to satisfy other Nasdaq listing requirements.
- If Nasdaq rejects the plan, it would notify SeaStar that the shares are subject to delisting. SeaStar could then appeal to a Nasdaq hearing panel.
The immediate issue is SeaStar’s ability to address the equity shortfall. The company has not stated the size of that shortfall or how it plans to regain compliance.
